Crossmark

Calcipotriol and 5-Fluorouracil Combination Therapy for the Treatment of Actinic Keratosis in the Clinic: A Review Article

Published Online: 2024-09-28

Published Print: 2024-10

Authors

Dlott, Anna H.

Spencer, Sara A.

Di Pasqua, Anthony J. https://orcid.org/0009-0005-8690-4792
License Information

Text and Data Mining valid from 2024-09-28

Version of Record valid from 2024-09-28
More Information

Article History

Accepted: 4 September 2024

First Online: 28 September 2024

Declarations

:

: No external funding was received for the preparation of this article. Anthony J. Di Pasqua is supported financially by the Massachusetts College of Pharmacy and Health Sciences.

: Anna H. Dlott and Anthony J. Di Pasqua have no conflicts of interest that are directly relevant to the content of this article. Sara A. Spencer is an employee of Otsuka Pharmaceutical.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: AHD: conceptualization, original draft preparation, reviewing, and editing; SAS: reviewing and editing; AJD: conceptualization, reviewing, and editing.

Document is current